Abstract
Effects of remote ischemic conditioning (RIC) in acute myocardial infarction (AMI) patients remain conflicting. We performed this meta-analysis of randomized clinical trials (RCTs) to evaluate the benefits of the RIC in patients with AMI. Potentially relevant RCTs were identified by searching PubMed, Embase, Cochrane Library, VIP, CNKI, and Wanfang database until November 2016. RCTs evaluating RIC using intermittent limb ischemia-reperfusion in AMI patients were included. Thirteen RCTs were identified and analyzed. Meta-analysis showed that RIC significantly reduced the area under the curve (AUC) of creatine kinase-myocardial band (CK-MB) (standardized mean difference [SMD] −0.29; 95% confidence intervals [CI] −0.44 to −0.14; P = 0.0002) and AUC of troponin T (SMD −0.22; 95% CI −0.37 to −0.08; P = 0.003). Risk ratio (RR) for ≥70% ST-segment resolution favored RIC group than the control group (RR 1.39; 95% CI 1.03–1.86; P = 0.03). RIC also significantly reduced all-cause mortality (RR 0.33; 95%CI 0.17–0.64; P = 0.001). Subgroup analyses on the CK-MB AUC and ST-segment resolution ≥70% rate showed that the effects of RIC appeared to be affected by the limb used, duration of RIC, and clinical setting. RIC may offer cardioprotective effects by improving ST-segment resolution and reducing the infarct size in AMI patients.
Highlights
Effects of remote ischemic conditioning (RIC) in acute myocardial infarction (AMI) patients remain conflicting
We aimed to evaluate the possible cardioprotective effects of Remote ischemic conditioning (RIC) induced by intermittent limb ischemia–reperfusion in patients with AMI by conducting a meta-analysis of randomized clinical trials (RCTs)
Of the 13 trials, 880 patients were randomized to RIC and 876 patients were allocated to the controls
Summary
Effects of remote ischemic conditioning (RIC) in acute myocardial infarction (AMI) patients remain conflicting. We performed this meta-analysis of randomized clinical trials (RCTs) to evaluate the benefits of the RIC in patients with AMI. RIC may offer cardioprotective effects by improving ST-segment resolution and reducing the infarct size in AMI patients. A number of studies have demonstrated the cardioprotective effects of RIC in terms of improved myocardial perfusion and reduced infarct size in patients undergoing primary PCI4–12 or thrombolysis[13,14,15,16] with conflicting findings. We aimed to evaluate the possible cardioprotective effects of RIC induced by intermittent limb ischemia–reperfusion in patients with AMI by conducting a meta-analysis of randomized clinical trials (RCTs)
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have